For how long is Mavyret typically administered for HCV treatment?

Mavyret is a fixed-dose combination medication used for the treatment of chronic hepatitis C virus (HCV) infection. It typically consists of a combination of glecaprevir and pibrentasvir. The standard treatment duration with Mavyret is 8 weeks for most patients with HCV genotypes 1-6, without the need for ribavirin or interferon. This shorter treatment duration makes Mavyret a convenient and effective option for HCV treatment. Option B (8 weeks) is the correct answer as it aligns with the typical treatment duration of Mavyret therapy.